Ferritin-armed extracellular vesicles with enhanced BBB penetration and tumor-targeting ability for synergistic therapy against glioblastoma
Abstract Glioblastoma multiforme (GBM) is an aggressive brain cancer with a high mortality rate and limited treatment options. Metabolism-based synergistic therapy holds promise for GBM treatment, however, its efficacy is significantly impeded by poor blood-brain barrier (BBB) penetration, inadequat...
Saved in:
| Main Authors: | Guihong Lu, Peiling Zhuang, Feng Li, Fan Zhang, Xiaoyan Li, Weixiu Wang, Hui Tan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Journal of Nanobiotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12951-025-03646-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma
by: Ioannis Ntafoulis, et al.
Published: (2024-12-01) -
Nanoparticles for Glioblastoma Treatment
by: Dorota Bartusik-Aebisher, et al.
Published: (2025-05-01) -
The role of extracellular vesicles in the diagnosis of glioblastoma progression
by: A. I. Ryabova, et al.
Published: (2020-11-01) -
Innovative nanoparticle-based therapeutic strategies against glioblastoma multiform: a focus on enhanced delivery systems and efficacy
by: Kehan Wang
Published: (2025-07-01) -
RBM10 deficiency promotes brain metastasis by modulating sphingolipid metabolism in a BBB model of EGFR mutant lung adenocarcinoma
by: Gang Xu, et al.
Published: (2025-03-01)